153 related articles for article (PubMed ID: 4156532)
1. Design of agents for stimulation of neostriatal dopaminergic mechanisms.
Costall B; Naylor RJ; Pinder RM
J Pharm Pharmacol; 1974 Oct; 26(10):753-6. PubMed ID: 4156532
[No Abstract] [Full Text] [Related]
2. Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.
Costall B; Naylor RJ
Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):83-98. PubMed ID: 4280020
[No Abstract] [Full Text] [Related]
3. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
Costall B; Naylor RJ; Cannon JG; Lee T
J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
[No Abstract] [Full Text] [Related]
4. Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
Costall B; Naylor RJ
Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):71-81. PubMed ID: 4280019
[No Abstract] [Full Text] [Related]
5. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.
Castellani S; Adams PM
Neuropharmacology; 1981 Apr; 20(4):371-4. PubMed ID: 7197334
[No Abstract] [Full Text] [Related]
6. The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.
Costall B; Naylor RJ
Eur J Pharmacol; 1973 Oct; 24(1):8-24. PubMed ID: 4796448
[No Abstract] [Full Text] [Related]
7. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
Fuxe K; Ungerstedt U
Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332
[No Abstract] [Full Text] [Related]
8. A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.
Thornburg JE; Moore KE
Neuropharmacology; 1974 Mar; 13(3):189-97. PubMed ID: 4858216
[No Abstract] [Full Text] [Related]
9. Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei.
Makanjuola RO; Dow RC; Ashcroft GW
Psychopharmacology (Berl); 1980; 71(3):227-35. PubMed ID: 6109349
[TBL] [Abstract][Full Text] [Related]
10. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
Cools AR; van Rossum JM
Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
[No Abstract] [Full Text] [Related]
11. Turning behavior induced by electrical stimulation of the nigro-neostriatal system of the rat.
Arbuthnott GW; Ungerstedt U
Exp Neurol; 1975 Apr; 47(1):162-72. PubMed ID: 164362
[No Abstract] [Full Text] [Related]
12. Striatal efferent fibers play a role in maintaining rotational behavior in the rat.
Marshall JF; Ungerstedt U
Science; 1977 Oct; 198(4312):62-4. PubMed ID: 897683
[TBL] [Abstract][Full Text] [Related]
13. Influence of dopaminergic agonists upon body temperature and behavior of spontaneously hypertensive and normotensive rats.
Martin JR; Quock RM
Proc West Pharmacol Soc; 1978; 21():451-3. PubMed ID: 567806
[No Abstract] [Full Text] [Related]
14. Genotypic variation in the dopaminergic inhibitory control of striatal and hippocampal cholinergic activity in mice.
Durkin TP; Hashem-Zadeh H; Mandel P; Kempf J; Ebel A
Pharmacol Biochem Behav; 1983 Jul; 19(1):63-70. PubMed ID: 6684780
[No Abstract] [Full Text] [Related]
15. The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour.
Cools AR
Arch Int Pharmacodyn Ther; 1971 Dec; 194(2):259-69. PubMed ID: 5126063
[No Abstract] [Full Text] [Related]
16. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.
Krueger BK; Forn J; Walters JR; Roth RH; Greengard P
Mol Pharmacol; 1976 Jul; 12(4):639-48. PubMed ID: 183096
[No Abstract] [Full Text] [Related]
17. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
[No Abstract] [Full Text] [Related]
18. Behavioral implications of dopaminergic neurons in the mesolimbic system.
Iversen SD; Koob GF
Adv Biochem Psychopharmacol; 1977; 16():209-14. PubMed ID: 560790
[No Abstract] [Full Text] [Related]
19. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
Owen F; Cross AJ; Waddington JL; Poulter M; Gamble SJ; Crow TJ
Life Sci; 1980 Jan; 26(1):55-9. PubMed ID: 7189005
[No Abstract] [Full Text] [Related]
20. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
Wolfarth S
Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
